全球玻璃体视网膜手术设备市场行业概况及 2031 年预测 – 市场分析和市场份额

玻璃体视网膜疾病会影响眼内视网膜和玻璃体结构。视网膜是眼球后部的感光层，可聚焦图像并通过视神经将信息传输到大脑。玻璃体是一种透明的凝胶，填充晶状体（位于眼睛前部）和视网膜之间的空间。全球玻璃体视网膜手术设备市场正在经历显着增长，这得益于糖尿病视网膜病变和老年性黄斑变性 (AMD) 等视网膜疾病发病率的不断上升。世界卫生组织报告称，全球至少有 22 亿人患有近视或远视障碍，对先进玻璃体视网膜手术解决方案的需求比以往任何时候都更加迫切。人口老龄化和糖尿病发病率上升推动了市场扩张，这导致这些使人衰弱的视网膜疾病患病率上升。因此，手术技术和成像系统的创新对于解决这一全球视力健康危机至关重要，为市场发展和改善患者治疗效果提供了新的机会。

 Data Bridge 市场研究市场报告提供了最新发展、市场份额、基于细分和区域分析的市场趋势、市场参与者的影响、新兴收入领域机会分析、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地理扩展、市场技术创新的详细信息。要获取有关市场的更多信息，请联系 Data Bridge 市场研究的专家分析师团队。我们的团队将帮助您做出明智的市场决策，以实现业务增长。

全球玻璃体视网膜手术设备市场分析和市场规模

Advances in surgical instruments, imaging systems, and laser technologies are revolutionizing the field, enabling more accurate diagnosis and effective treatment of retinal disorders. These cutting-edge technologies are not only improving surgical performance but also addressing the growing need for advanced solutions amidst increasing rates of retinal diseases, such as diabetic retinopathy and age-related macular degeneration (AMD). As a result, Databridge Market Research dived into comprehensively analyzing the market and unveiled that the Global Phobic Disorders Treatment   Market is increasing at a CAGR of 3.04%. Our detailed analysis forecasts that the market is valued at USD 1.69 billion in 2023 and is expected to grow upto USD 2.15 billion by 2031. Our meticulously created report, developed through comprehensive research and analytics, is a distinguished paper that unveils eye-opening data about the market.

Global Vitreoretinal Surgery Devices Market Dynamics

Global Vitreoretinal Surgery Devices Market Growth Drivers

Rise in Aging Population

Aging global population is significantly contributing to the increased prevalence of retinal diseases. For instance, age-related macular degeneration (AMD) is a leading cause of vision loss in individuals aged 50 and older. According to the National Eye Institute, AMD affects more than 2.1 million Americans. As our population ages, and the “baby boomers” advance into their 60's and 70's, the National Eye Institute estimates 3.7 million Americans will have moderate to severe AMD by 2030.  Such demographic shift underscores the growing demand for advanced vitreoretinal surgical solutions to address the needs of an expanding population affected by age-related vision conditions. Consequently driving Global Vitreoretinal Surgery Devices Market growth.

Rising Organizational support

The increasing prevalence of diabetes is a significant driver for the global vitreoretinal surgery devices market. According to the International Diabetes Federation (IDF), the number of adults aged 20–79 living with diabetes is projected to rise from 537 million in 2021 to 643 million by 2030 and reach 783 million by 2045. As diabetes becomes more widespread, diabetic retinopathy, a common complication that is a leading cause of vision impairment, becomes more prevalent. Such surge in diabetic cases directly fuels the demand for advanced vitreoretinal surgical solutions to manage and treat diabetic.

Global Vitreoretinal Surgery Devices Market Growth Opportunities

Robotic-Assisted Surgery

The integration of robotic-assisted surgical systems into vitreoretinal procedures represents a transformative advancement, significantly enhancing both precision and efficiency. For instance, the use of the NGENUITY 3D Visualization System, which combines robotic assistance with high-definition 3D visualization, allows for intricate maneuvers and better visualization of the retinal anatomy, leading to more precise surgical interventions. As robotic-assisted technologies continue to evolve, they present substantial opportunities in the global vitreoretinal surgery devices market growth.

Growing need for efficiency and accuracy

Stellaris Elite by Bausch + Lomb utilizes hypersonic technology to offer unprecedented precision and control during vitreoretinal procedures. By operating at high frequencies, it allows for more accurate manipulation of retinal tissues and efficient removal of vitreous gel, enhancing surgical outcomes and reducing recovery times. The increases in demand for advanced, high-performance surgical tools fosters the Global Vitreoretinal Surgery Devices Market growth.

Global Vitreoretinal Surgery Devices Market Growth Challenges

Technological Obsolescence

The swift pace of technological advancement in vitreoretinal surgery presents a major challenge, as it can lead to frequent updates and potential obsolescence of existing devices. For instance, innovations such as high-definition 3D visualization systems and AI-driven diagnostic tools can quickly render older technologies outdated. This relentless evolution compels manufacturers to continually innovate and manage their product lifecycle effectively, navigating the complexities of keeping pace with technological progress while ensuring their devices remain competitive in the global market hampers the Global Vitreoretinal Surgery Devices Market growth.

Variability in Symptom Presentation

The growing availability of alternative treatments poses a significant challenge to the vitreoretinal surgery devices market, as pharmacological therapies and less invasive procedures may reduce the demand for traditional surgical interventions. For instance, the introduction of new anti-VEGF (vascular endothelial growth factor) drugs, such as Lucentis and Eylea, has provided effective pharmacological options for managing conditions like age-related macular degeneration (AMD) and diabetic retinopathy. These advancements in drug therapy can diminish the need for surgical procedures, impacting the Global Vitreoretinal Surgery Devices Market growth.

Global Vitreoretinal Surgery Devices Market Growth Restraints

Regulations restraining market expansion

在欧盟，医疗器械法规 (MDR) 要求进行全面的记录和严格的合规性评估，包括需要进行广泛的临床评估和上市后监测，如法规 (EU) 2017/745 中所述。如此严格的监管要求可能会延长新技术的上市时间并增加制造商的负担，从而可能减缓全球玻璃体视网膜手术设备市场的增长和玻璃体视网膜手术领域的创新。

全球玻璃体视网膜手术设备市场范围和趋势

• 睫状体平坦部玻璃体切除术 (PPV) 是玻璃体视网膜手术中常见的手术方法，可进入眼后节治疗视网膜脱离、玻璃体积血和黄斑裂孔等疾病。该技术涉及通过睫状体平坦部（眼白中的无血管区域）从视网膜中提取玻璃体液和疤痕组织。
• megaTRON S4HPS 是目前最强大的眼科手术系统之一，适用于前后段手术。其 UNO Colorline MACH2 玻璃体切割器切割速度高达 12,000 cpm。

全球玻璃体视网膜手术设备市场区域分析 – 市场趋势

关键见解

• 北美市场凭借先进的医疗基础设施和高创新技术采用率而处于领先地位。美国和加拿大受益于大量研发投资、视网膜疾病的高发病率以及支持性报销政策，推动了强劲的市场增长。
• 欧洲表现出强劲增长势头，这得益于视网膜疾病的高发性和支持性医疗保健系统。尽管 MDR 法规十分严格，但德国、法国和英国等主要市场仍因采用先进的玻璃体视网膜设备而蓬勃发展。
• 亚太地区正在经历蓬勃发展，这得益于医疗保健投资的增加以及中国和印度等国家视网膜疾病患病率的上升。意识的增强和医疗基础设施的改善正在加速市场增长，具有巨大的创新和应用潜力。
• 拉丁美洲正处于上升趋势，得益于巴西和墨西哥医疗支出的增加和基础设施的改善。人们对视网膜疾病的认识不断提高，需求不断增加，尽管经济波动和先进技术获取渠道各有不同，但仍为市场增长提供了机会。
• 在中东和非洲，由于医疗保健投资增加和糖尿病视网膜病变发病率上升，市场正在迅速扩张，尤其是在阿联酋和南非。这一增长创造了良好的机会，该地区的医疗保健服务和基础设施不断改善。

全球玻璃体视网膜手术设备市场领先企业

• 爱尔康公司
• 艾尔建
• 博士伦公司
• 卡尔蔡司医疗技术公司
• 荷兰眼科研究中心国际 BV
• 格劳科斯公司
• 豪雅公司
• ICON 集团
• 稲波产业株式会社
• 强生服务公司
• MedOne Surgical, Inc.
• 新世界医疗有限公司
• 诺华公司
• 奥特利仪器公司
• 眼科
• Paragon Care Group Australia Pty Ltd.
• 游隼外科
• 斯塔尔外科
• 蔡司国际

全球玻璃体视网膜手术设备市场最新发展

• 2023 年 12 月，法国投资集团 Eurazeo 将把其在 DORC 的全部股份出售给蔡司。此次收购将使蔡司能够扩大其玻璃体视网膜手术器械的供应范围。

• 2024年6月，致力于帮助人们看得更清楚的眼科护理全球领导者爱尔康宣布，UNITY玻璃体视网膜白内障系统 (VCS) 和 UNITY 白内障系统 (CS) 已获得美国食品药品监督管理局 (FDA) 510(k) 批准。

SKU-63838